KalVista Pharmaceuticals, Inc. ($KALV)
Filing Information
| Accession Number | 0001366244-26-000006 |
|---|---|
| Form Type | 4 |
| Filing Date | Apr 20, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
50,174
Total Value
$193,065.67
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Apr 16, 2026 | Exercise/Conversion | 20,312 | โ | โ | 472,127 | Direct | โ | View Details | |
Director | Common Stock | โ | Apr 17, 2026 | Sale | 9,550 | $20.22 | $193,065.67 | 462,577 | Direct | โ | View Details | |
Director | Restricted Stock Unit | Derivative | Apr 16, 2026 | Exercise/Conversion | 20,312 | $0.00 | $0.00 | 304,688 | Direct | โ | View Details |